Basic Study
Copyright ©The Author(s) 2017.
World J Clin Cases. Jan 16, 2017; 5(1): 1-8
Published online Jan 16, 2017. doi: 10.12998/wjcc.v5.i1.1
Table 1 The primary antibodies used for immunohistochemistry
AntibodyDilutionCloneManufacturer
LCAPredilutedPD7/26, 2B11Nichirei Biosciences, Tokyo
MPO1:200PolyclonalDakoCytomation, Glostrup, Denmark
CD3PredilutedPS1Nichirei Biosciences
CD4Prediluted4B12Nichirei Biosciences
CD81:50C8/144BDakoCytomation
CD201:50L26DakoCytomation
Table 2 The numbers of inflammatory cells per tissue microarray core
Maximun positive cell counts/coreMinimun positive cell counts/coreAverage/coreStandard deviation/coreNo. of analyzable cores
LCA13962733108.272734.79136
MPO109113882692.391830.47131
CD314702741967.062058.45130
CD465830583.01934.52134
CD8557210919.441034.35131
CD2070974467.95834.74133
CD6811355972452.992043.92135
Table 3 Single linear regression analysis of the relationship between E-cadherin expression and the type of inflammatory cells
CellsRegression equationAdjusted R2RStandard errorP-value
LCAEHS = 117.67879 − 0.0029223 × LCA0.02160.1546.57930.0482
CD20EHS = 112.37344 − 0.0083497 × CD200.01530.1245.84660.083
CD3EHS = 119.86794 − 0.0050479 × CD30.04210.2145.71070.011
CD4EHS = 109.63264 − 0.0003939 × CD4< 0.0001n/a47.19130.9285
CD8EHS = 121.37735 − 0.0146326 × CD80.10110.3243.67070.0001
MPOEHS = 104.23773 + 0.0012811 × MPO−0.00523n/a46.96470.5701
CD68EHS = 113.83072 − 0.0023317 × CD680.00290.0546.86660.2412
Table 4 Clinicopathologic features of the patients with gallbladder cancer (n = 50) n (%)
AgeMean ± SD68.7 ± 8.4
GenderMale15 (30.0)
Female35 (70.0)
Differentiation of invasive frontG116 (32.0)
G219 (38.0)
G315 (30.0)
T-stageT218 (36.0)
T328 (56.0)
T44 (8.0)
NN017 (34.0)
N133 (66.0)
No. of CD8-positive cells (means of analyzable cores in each case)Median ± SD580.0 ± 1154.5
E-cadherin histological scoreMedian ± SD114.3 ± 37.8